Tumor necrosis factor α release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patients

Por Nabatian, Adam S, Bashir, Muhammad M, Wysocka, Maria, Sharma, Meena, Werth, Victoria P
Publicado em 2012

Immune Suppression by Recombinant Interleukin (rIL)-12 Involves Interferon γ Induction of Nitric Oxide Synthase 2 (iNOS) Activity: Inhibitors of NO Generation Reveal the Extent of...

Por Koblish, Holly Kurzawa, Hunter, Christopher A., Wysocka, Maria, Trinchieri, Giorgio, Lee, William M.F.
Publicado em 1998

Simultaneous Inhibition of mTOR-Containing Complex 1 (mTORC1) and MNK Induces Apoptosis of Cutaneous T-Cell Lymphoma (CTCL) Cells

Por Marzec, Michal, Liu, Xiaobin, Wysocka, Maria, Rook, Alain H., Odum, Niels, Wasik, Mariusz A.
Publicado em 2011

Increased Programmed Death-1 Expression on CD4(+) T Cells in Cutaneous T-Cell Lymphoma: Implications for Immune Suppression

Por Samimi, Sara, Benoit, Bernice, Evans, Katherine, Wherry, E. John, Showe, Louise, Wysocka, Maria, Rook, Alain H.
Publicado no Arch Dermatol (2010)

Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities

Por Cedeno-Laurent, Filiberto, Singer, Elisha M., Wysocka, Maria, Benoit, Bernice M., Vittorio, Carmela, Kim, Ellen J., Yosipovitch, Gil, Rook, Alain H.
Publicado no Clin Immunol (2015)

Expression and Oncogenic Role of Brk (PTK6/Sik) Protein Tyrosine Kinase in Lymphocytes

Por Kasprzycka, Monika, Majewski, Miroslaw, Wang, Zhi-Jong, Ptasznik, Andrzej, Wysocka, Maria, Zhang, Qian, Marzec, Michal, Gimotty, Phyllis, Crompton, Mark R., Wasik, Mariusz A.
Publicado em 2006

Synergistic Enhancement of Cellular Immune Responses by the Novel Toll Receptor 7/8 Agonist 3M 007 and Interferon-γ: Implications for Therapy of Cutaneous T-Cell Lymphoma

Por Wysocka, Maria, Dawany, Noor, Benoit, Bernice, Kossenkov, Andrew V., Troxel, Andrea B., Gelfand, Joel M., Kelly-Sell, Michael, Showe, Louise C., Rook, Alain H.
Publicado em 2011

Inhibition of Cell-Mediated Immunity by the Histone Deacetylase Inhibitor Vorinostat:Implications for Therapy of Cutaneous T-Cell Lymphoma

Por Stephen, Sasha, Morrissey, Kelly A., Benoit, Bernice M., Kim, Ellen J., Vittorio, Carmela C., Nasta, Sunita D., Showe, Louise C., Wysocka, Maria, Rook, Alain H.
Publicado em 2011

Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)

Por Marzec, Michal, Zhang, Qian, Goradia, Ami, Raghunath, Puthiyaveettil N., Liu, Xiaobin, Paessler, Michele, Wang, Hong Yi, Wysocka, Maria, Cheng, Mangeng, Ruggeri, Bruce A., Wasik, Mariusz A.
Publicado em 2008

The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T cell lymphoma patients

Por Kelly-Sell, Michael J., Kim, Youn H., Strauss, Suzanne, Benoit, Bernice, Harrison, Cameron, Sutherland, Katherine, Armstrong, Randall, Weng, Wen-Kai, Showe, Louise C., Wysocka, Maria, Rook, Alain H.
Publicado em 2012

TIGIT and Helios are highly expressed on CD4(+) T cells in Sezary syndrome patients

Por Jariwala, Neha, Benoit, Bernice, Kossenkov, Andrew V., Oetjen, Landon K., Whelan, Timothy M., Cornejo, Christine M., Takeshita, Junko, Kim, Brian S., Showe, Louise C., Wysocka, Maria, Rook, Alain H.
Publicado no J Invest Dermatol (2016)

Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-α receptor

Por Lin, Julie H., Kim, Ellen J., Bansal, Anand, Seykora, John, Richardson, Stephen K., Cha, Xian-Yuan, Zafar, Sarosh, Nasta, Sunita, Wysocka, Maria, Benoit, Bernice, Rook, Alain H., Fakharzadeh, Steven S.
Publicado em 2008

CD164 and FCRL3 are highly expressed on CD4+CD26-T cells in Sézary syndrome patients

Por Wysocka, Maria, Kossenkov, Andrew V., Benoit, Bernice M., Troxel, Andrea B., Singer, Elisha, Schaffer, Andras, Kim, Brian, Dentchev, Tzvete, Nagata, Satoshi, Ise, Tomoko, Showe, Louise C., Rook, Alain H.
Publicado em 2013

Immunopathogenesis and therapy of cutaneous T cell lymphoma

Por Kim, Ellen J., Hess, Stephen, Richardson, Stephen K., Newton, Sara, Showe, Louise C., Benoit, Bernice M., Ubriani, Ravi, Vittorio, Carmela C., Junkins-Hopkins, Jacqueline M., Wysocka, Maria, Rook, Alain H.
Publicado em 2005

Immunopathogenesis and therapy of cutaneous T cell lymphoma

Por Kim, Ellen J., Hess, Stephen, Richardson, Stephen K., Newton, Sara, Showe, Louise C., Benoit, Bernice M., Ubriani, Ravi, Vittorio, Carmela C., Junkins-Hopkins, Jacqueline M., Wysocka, Maria, Rook, Alain H.
Publicado em 2007

Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma

Por Kari, Laszlo, Loboda, Andrey, Nebozhyn, Michael, Rook, Alain H., Vonderheid, Eric C., Nichols, Calen, Virok, Dezso, Chang, Celia, Horng, Wen-Hwai, Johnston, James, Wysocka, Maria, Showe, Michael K., Showe, Louise C.
Publicado em 2003

Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma

Por Rook, Alain H., Gelfand, Joel C., Wysocka, Maria, Troxel, Andrea B., Benoit, Bernice, Surber, Christian, Elenitsas, Rosalie, Buchanan, Marie A., Leahy, Deborah S., Watanabe, Rei, Kirsch, Ilan R., Kim, Ellen J., Clark, Rachael A.
Publicado no Blood (2015)

CD164 identifies CD4(+) T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox and miR-214

Por Benoit, Bernice M., Jariwala, Neha, O’Connor, Geraldine, Oetjen, Landon K., Whelan, Timothy M., Werth, Adrienne, Troxel, Andrea B., Sicard, Hélène, Zhu, Lisa, Miller, Christopher, Takeshita, Junko, McVicar, Daniel W., Kim, Brian S., Rook, Alain H., Wysocka, Maria
Publicado no Arch Dermatol Res (2016)

Immune Modulators as Therapeutic Agents for Cutaneous T-Cell Lymphoma

Por Rook, Alain H., Benoit, Bernice, Kim, Ellen J., Vittorio, Carmela C., Anshelevich, Sasha, Raphael, Brian A., Introcaso, Camille E., Gardner, Jennifer M., Evans, Katherine G., Morrissey, Kelly, Samimi, Sara, Musiek, Amy C., Showe, Louise C., Wasik, Mariusz A., Wysocka, Maria
Publicado em 2010